EIKN

NASDAQ open

Eikon Therapeutics

4.80 USD
▲+0.04+0.84%
盘后 5.50 0.00%
2026-11-20
市值
$256.84M
市盈率
—
EPS
-9.28
股息率
—
52 周区间
4.72 – 17.40
成交量
426.12K
Beta
—
目标价
24.00
52W 低 4.7252W 高 17.40
价格走势

公司简介

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent W...